Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.

Pediatric research - 1 Sept 2015

Knerr Ina, Coss Karen Patricia, Kratzsch Jürgen, Crushell Ellen, Clark Anne, Doran Peter, Shin Yoon, Stöckmann Henning, Rudd Pauline Mary, Treacy Eileen

Abstract excerpt

BACKGROUND: Classical galactosemia is caused by severe galactose-1-phosphate uridyltransferase deficiency. Despite life-long galactose-restriction, many patients experience long-term complications. Intoxication by galactose and its metabolites as well as over-restriction of galactose may contribute to the pathophysiology. We provided temporary low-dose galactose supplements to patients. We assessed tolerance and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone and Bones
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endocrine System

Share to Galactose

Share to Galactosemias

Share to Lactose

Share to Leptin

Share to Receptors, Leptin

Source

Identifiers

PMID: 26053138
DOI: 10.1038/pr.2015.107

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.PMID 26053138Read ↗

Current and Future Treatments for Classic GalactosemiaSemantic proximity Read ↗

Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and TreatmentSemantic proximity Read ↗

Reshaping the Treatment Landscape of a Galactose Metabolism DisorderSemantic proximity Read ↗

Galactose-1-phosphate uridyltransferase deficiency: A literature review of the putative mechanisms of short and long-term complications and allelic variants.Semantic proximity Read ↗

Hereditary galactosemia.Semantic proximity Read ↗

Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.Semantic proximity Read ↗

Classic galactosemia: dietary dilemmasSemantic proximity Read ↗

Pathophysiology and management of classic galactosemic primary ovarian insufficiencySemantic proximity Read ↗

Sweet and sour: an update on classic galactosemiaSemantic proximity Read ↗

Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomesSemantic proximity Read ↗

Galactosemia: The good, the bad, and the unknownSemantic proximity Read ↗

The 1-13 C galactose breath test in GALT deficient patients distinguishes NBS detected variant patients but does not predict outcome in classical phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.